Trials / Completed
CompletedNCT06905717
The T2D Profile - Studies of the Omics Profile in Type 2 Diabetes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- All
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The T2D Profile study examines the longitudinal molecular profiles of newly diagnosed type 2 diabetes (T2D), before and during guideline-based diabetes treatment.
Detailed description
The study included a total of 3 visits: At baseline and after 1 and 3 months of diabetes treatment according to standard of care. Visits included clinical examinations, questionnaires and clinical chemistry. In addition, samples were collected at each visits for comprehensive molecular profiling including proteomics, genomics, transcriptomics, metabolomics, lipidomics, antibody profiling, mass cytometry and gene profiling of fecal microbiota.
Conditions
Timeline
- Start date
- 2016-06-15
- Primary completion
- 2018-06-25
- Completion
- 2018-12-31
- First posted
- 2025-04-01
- Last updated
- 2025-04-01
Source: ClinicalTrials.gov record NCT06905717. Inclusion in this directory is not an endorsement.